UBS Maintains Buy on Cabot, Raises Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector has reaffirmed a Buy rating on Cabot Corporation (NYSE:CBT) and increased the price target from $83 to $90.
December 14, 2023 | 3:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Joshua Spector maintains a Buy rating on Cabot Corporation and raises the price target to $90.
The increase in price target by a reputable analyst like Joshua Spector from UBS typically signals a positive outlook on the company's future performance and is often taken as a bullish sign by the market. This could lead to increased investor confidence and a potential short-term rise in the stock price of Cabot Corporation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100